Tara Fox

615 total citations
5 papers, 225 citations indexed

About

Tara Fox is a scholar working on Neurology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tara Fox has authored 5 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 1 paper in Cellular and Molecular Neuroscience and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Tara Fox's work include Parkinson's Disease Mechanisms and Treatments (4 papers), Neurological disorders and treatments (3 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Tara Fox is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (4 papers), Neurological disorders and treatments (3 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Tara Fox collaborates with scholars based in United States, Germany and Canada. Tara Fox's co-authors include Jesse M. Cedarbaum, Minhua Yang, Mirosław Bryś, Danielle Graham, Aaron Ellenbogen, Ira Goodman, E. Koenig, Andreas Weihofen, Mackenzie Welch and Jason Aldred and has published in prestigious journals such as Neurology, Movement Disorders and Lung Cancer.

In The Last Decade

Tara Fox

5 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tara Fox United States 5 157 81 58 54 46 5 225
Kimiko Inoue Japan 9 150 1.0× 49 0.6× 79 1.4× 110 2.0× 40 0.9× 22 309
Xianghua He China 9 136 0.9× 55 0.7× 42 0.7× 64 1.2× 44 1.0× 21 229
Bjørg Warø Norway 5 194 1.2× 65 0.8× 58 1.0× 66 1.2× 47 1.0× 5 246
Simone Grannò United Kingdom 7 108 0.7× 73 0.9× 66 1.1× 145 2.7× 33 0.7× 7 298
Martina de Majo United States 6 57 0.4× 28 0.3× 29 0.5× 108 2.0× 57 1.2× 9 199
Lucas Caldi Gomes Germany 9 112 0.7× 66 0.8× 45 0.8× 187 3.5× 46 1.0× 16 337
Geshanthi Hondhamuni United Kingdom 7 182 1.2× 50 0.6× 135 2.3× 98 1.8× 76 1.7× 7 293
Daniela Corongiu Italy 8 113 0.7× 61 0.8× 39 0.7× 96 1.8× 47 1.0× 12 239
Edoardo Bellini Italy 8 69 0.4× 50 0.6× 38 0.7× 99 1.8× 90 2.0× 11 231
Nicole Washecka United States 4 184 1.2× 40 0.5× 42 0.7× 81 1.5× 90 2.0× 4 262

Countries citing papers authored by Tara Fox

Since Specialization
Citations

This map shows the geographic impact of Tara Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Fox more than expected).

Fields of papers citing papers by Tara Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Fox. The network helps show where Tara Fox may publish in the future.

Co-authorship network of co-authors of Tara Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Fox. A scholar is included among the top collaborators of Tara Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Fox. Tara Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Hutchison, R. Matthew, Kyle Fraser, Minhua Yang, et al.. (2024). Cinpanemab in Early Parkinson Disease. Neurology. 102(5). e209137–e209137. 18 indexed citations
2.
Hutchison, R. Matthew, Karleyton C. Evans, Tara Fox, et al.. (2021). Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson’s disease trial. BMC Neurology. 21(1). 459–459. 13 indexed citations
3.
Bryś, Mirosław, Laura Fanning, Serena Hung, et al.. (2019). Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054. Movement Disorders. 34(8). 1154–1163. 139 indexed citations
4.
Bryś, Mirosław, Aaron Ellenbogen, Laura Fanning, et al.. (2018). Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Anti-Alpha-Synuclein Antibody BIIB054 in Patients with Parkinson’s Disease (S26.001). Neurology. 90(15_supplement). 17 indexed citations
5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimiko Inoue Breakdown of academic impact, for papers by Xianghua He Breakdown of academic impact, for papers by Bjørg Warø Breakdown of academic impact, for papers by Simone Grannò Breakdown of academic impact, for papers by Martina de Majo Breakdown of academic impact, for papers by Lucas Caldi Gomes Breakdown of academic impact, for papers by Geshanthi Hondhamuni Breakdown of academic impact, for papers by Daniela Corongiu Breakdown of academic impact, for papers by Edoardo Bellini Breakdown of academic impact, for papers by Nicole Washecka
Rankless by CCL
2026